Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism
Pharmacopsychiatry DOI: 10.1055/a-1909-2198 Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents | Full text
Source: Pharmacopsychiatry - Category: Psychiatry Authors: Papadopoulos, Konstantinos I. Papadopoulou, Alexandra Aw, Tar-Choon Tags: Letter to the Editor Source Type: research